Summary
CME Group Inc. (CME) filed a Current Report on Form 8-K on August 7, 2008, primarily to disclose the mailing of a Proxy Supplement dated August 7, 2008. This supplement was sent to holders of CME Group Class A common stock, NYMEX Holdings common stock, and NYMEX Class A members. It amends and provides additional information related to the previously filed joint proxy statement/prospectus dated July 21, 2008. The filing indicates that the supplement is part of the ongoing process related to the acquisition of NYMEX Holdings by CME Group. Investors should note that this 8-K filing itself does not contain new financial results or operational updates. Its significance lies in providing further details and clarifications pertinent to the upcoming shareholder and member votes required for the completion of the NYMEX acquisition. The attached Exhibit 99.1, the Proxy Supplement, is the critical document for understanding any revised terms, risks, or procedural information related to this significant corporate event.
Key Highlights
- 1CME Group mailed a Proxy Supplement dated August 7, 2008, to relevant stakeholders.
- 2The supplement is an addition to the joint proxy statement/prospectus previously filed on July 21, 2008.
- 3The mailing was directed to holders of CME Group Class A common stock, NYMEX Holdings common stock, and NYMEX Class A members.
- 4This filing serves as a notification of updated information for those involved in the voting process for the proposed transaction.
- 5The document is filed under Item 8.01 (Other Events) of the Form 8-K.
- 6The Proxy Supplement is attached as Exhibit 99.1 to this 8-K filing.
- 7The filing is related to the acquisition of NYMEX Holdings, Inc. by CME Group Inc.